Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.58 Insider Own0.10% Shs Outstand155.37M Perf Week0.80%
Market Cap6.83B Forward P/E- EPS next Y-0.51 Insider Trans327.51% Shs Float113.55M Perf Month-24.79%
Income-238.00M PEG- EPS next Q-0.44 Inst Own97.57% Short Float8.36% Perf Quarter-11.02%
Sales366.20M P/S18.65 EPS this Y17.50% Inst Trans0.85% Short Ratio5.42 Perf Half Y0.28%
Book/sh4.11 P/B10.43 EPS next Y72.70% ROA-34.50% Target Price59.00 Perf Year48.54%
Cash/sh4.09 P/C10.48 EPS next 5Y25.00% ROE-39.40% 52W Range23.77 - 58.72 Perf YTD0.21%
Dividend- P/FCF- EPS past 5Y-10.90% ROI-35.40% 52W High-26.99% Beta1.71
Dividend %- Quick Ratio7.20 Sales past 5Y390.00% Gross Margin94.50% 52W Low80.35% ATR2.15
Employees550 Current Ratio7.30 Sales Q/Q43.00% Oper. Margin-67.80% RSI (14)38.42 Volatility3.33% 3.82%
OptionableYes Debt/Eq0.00 EPS Q/Q4.40% Profit Margin-65.00% Rel Volume0.68 Prev Close43.52
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout- Avg Volume1.75M Price42.87
Recom1.60 SMA20-11.58% SMA50-12.37% SMA200-5.13% Volume1,184,816 Change-1.49%
Jul-07-20Upgrade Stifel Hold → Buy $41 → $71
Apr-16-20Initiated Jefferies Buy $60
Mar-31-20Upgrade Goldman Neutral → Buy $45 → $72
Mar-06-20Initiated Citigroup Buy $69
Dec-16-19Initiated Guggenheim Buy $60
Oct-24-19Initiated Oppenheimer Perform $44
Oct-01-19Initiated RBC Capital Mkts Outperform $60
Sep-13-19Upgrade SVB Leerink Mkt Perform → Outperform
Sep-10-19Upgrade Canaccord Genuity Hold → Buy $29 → $50
Jul-23-19Reiterated Needham Buy $40 → $34
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Aug-05-20 06:25PM  
04:05PM  
Jul-31-20 08:00PM  
Jul-30-20 03:37PM  
Jul-29-20 12:33PM  
09:00AM  
Jul-28-20 11:33AM  
Jul-22-20 04:05PM  
12:32PM  
Jul-21-20 04:24PM  
03:46AM  
Jul-20-20 05:30PM  
04:03PM  
04:02PM  
Jul-12-20 08:54PM  
Jul-08-20 06:51AM  
Jul-07-20 10:42AM  
Jun-29-20 03:50PM  
Jun-17-20 07:36PM  
Jun-16-20 10:47AM  
06:00AM  
Jun-15-20 09:00AM  
Jun-08-20 03:37AM  
Jun-06-20 11:31AM  
Jun-02-20 09:00AM  
07:27AM  
May-28-20 09:00AM  
May-27-20 12:15PM  
May-26-20 09:00AM  
May-21-20 11:28PM  
09:00AM  
May-09-20 08:02AM  
May-08-20 10:31PM  
10:55AM  
May-07-20 06:10PM  
04:06PM  
04:05PM  
May-05-20 04:05PM  
Apr-30-20 12:34PM  
Apr-15-20 04:05PM  
Apr-13-20 09:43AM  
Mar-27-20 11:31AM  
Mar-24-20 04:23PM  
Mar-22-20 05:04PM  
Mar-20-20 02:11PM  
Mar-17-20 12:06AM  
Mar-03-20 05:50PM  
Feb-28-20 08:35PM  
01:54PM  
Feb-27-20 11:13AM  
Feb-26-20 05:35PM  
04:05PM  
Feb-24-20 09:00AM  
Feb-19-20 12:31PM  
Feb-12-20 09:00AM  
Feb-05-20 06:13AM  
Jan-29-20 05:00AM  
Jan-17-20 08:45AM  
Jan-10-20 11:54AM  
Jan-07-20 09:00AM  
Dec-23-19 02:47PM  
11:30AM  
Dec-22-19 07:12AM  
Dec-19-19 10:18AM  
Dec-18-19 04:05PM  
Dec-17-19 09:11AM  
Dec-12-19 11:56AM  
Dec-11-19 09:04AM  
Dec-06-19 07:39AM  
05:00AM  
Dec-05-19 11:01PM  
04:08PM  
10:08AM  
07:14AM  
Dec-04-19 08:45PM  
08:45PM  
Dec-02-19 02:57PM  
Dec-01-19 09:30AM  
07:27AM  
Nov-27-19 10:00AM  
Nov-25-19 04:03PM  
08:58AM  
Nov-21-19 09:56AM  
Nov-18-19 10:17AM  
Nov-12-19 08:18AM  
Nov-11-19 04:48PM  
09:28AM  
09:00AM  
Nov-07-19 05:13AM  
Nov-06-19 10:00AM  
09:00AM  
Nov-04-19 05:40PM  
09:00AM  
Oct-30-19 07:25PM  
04:15PM  
04:05PM  
Oct-29-19 08:46AM  
Oct-28-19 11:22AM  
Oct-25-19 12:12PM  
Oct-24-19 04:58PM  
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YANG MICHAEL J.EVP and CCOJul 07Option Exercise23.0027,250626,77032,454Jul 09 06:26 PM
YANG MICHAEL J.EVP and CCOJul 07Sale56.2527,2501,532,7865,204Jul 09 06:26 PM
Stankovic Srdjan R.PresidentJun 19Option Exercise18.1216,452298,11027,786Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 19Sale50.1216,452824,51511,334Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Option Exercise18.8165,8431,238,69777,177Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Sale50.0165,8433,292,72911,334Jun 19 06:55 PM
DAVIS STEPHENCEOMay 14Option Exercise19.6588,5421,739,850100,351May 15 07:11 PM
DAVIS STEPHENCEOMay 14Sale45.6288,5424,039,10511,809May 15 07:11 PM
DAVIS STEPHENCEOMay 13Option Exercise19.65111,4582,190,150123,267May 15 07:11 PM
DAVIS STEPHENCEOMay 13Sale46.35111,4585,165,58711,809May 15 07:11 PM
Daly James MDirectorMay 11Option Exercise26.3926,250692,70026,250May 13 06:00 PM
Daly James MDirectorMay 11Sale51.1326,2501,342,1780May 13 06:00 PM
DAVIS STEPHENCEOApr 30Sale49.216,770333,15211,809May 01 06:00 PM
YANG MICHAEL J.EVP and CCOApr 30Sale49.211,50173,8645,204May 01 06:00 PM
KIM AUSTIN D.EVP & General CounselApr 30Sale49.221,07252,7642,441May 01 06:00 PM
Stankovic Srdjan R.PresidentApr 30Sale49.214,308211,99711,334May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 30Sale49.221,05051,6812,195May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Option Exercise25.1210,000251,20010,000May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Sale50.7410,000507,3530May 01 06:00 PM
Stankovic Srdjan R.PresidentApr 23Option Exercise20.6718,949391,70424,976Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 23Sale50.0718,949948,7296,027Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 22Option Exercise19.7754,0191,067,95660,046Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 22Sale50.0254,0192,701,9066,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Option Exercise19.65100,0001,965,000106,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Sale50.15100,0005,015,4506,027Apr 22 06:30 PM
BAKER BROS. ADVISORS LPDirectorMar 18Buy33.52135,8974,555,10138,433,977Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 17Buy32.84219,8007,218,90738,309,339Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 16Buy31.51694,30321,878,01738,107,749Mar 18 06:47 PM
Brege LauraDirectorJan 07Option Exercise1.7510,00017,50010,000Jan 08 06:01 PM
Brege LauraDirectorJan 07Sale42.1910,000421,9000Jan 08 06:01 PM
YANG MICHAEL J.EVP and CCODec 12Option Exercise31.09105,4793,279,377107,978Dec 13 05:35 PM
YANG MICHAEL J.EVP and CCODec 12Sale44.46105,4794,689,2632,499Dec 13 05:35 PM
KIM AUSTIN D.EVP & General CounselDec 11Option Exercise17.5817,500307,65018,009Dec 13 05:34 PM
KIM AUSTIN D.EVP & General CounselDec 11Sale45.0617,500788,576509Dec 13 05:34 PM
Ridloff ElenaEVP and CFODec 09Option Exercise15.8136,000569,16036,000Dec 11 06:29 PM
YANG MICHAEL J.EVP and CCODec 09Option Exercise35.8614,521520,72316,144Dec 11 06:30 PM
YANG MICHAEL J.EVP and CCODec 09Sale50.4614,521732,7921,623Dec 11 06:30 PM
Ridloff ElenaEVP and CFODec 09Sale49.6636,0001,787,8530Dec 11 06:29 PM
DAVIS STEPHENCEODec 05Option Exercise19.65150,0002,947,500152,954Dec 06 06:25 PM
DAVIS STEPHENCEODec 05Sale52.34150,0007,851,3002,954Dec 06 06:25 PM
Stankovic Srdjan R.PresidentNov 19Sale46.412,160100,2466,027Nov 21 05:37 PM
Miller Eric AlejandroController & PAOOct 15Sale39.651475,829270Oct 17 06:26 PM
YANG MICHAEL J.EVP and CCOOct 15Sale39.6587734,7731,623Oct 17 06:25 PM
Stankovic Srdjan R.PresidentOct 15Sale39.651,03140,8791,937Oct 17 06:24 PM
DAVIS STEPHENCEOOct 15Sale39.652,983118,2762,954Oct 17 06:23 PM
DAVIS STEPHENCEOOct 10Option Exercise19.65120,2082,362,087120,208Oct 11 05:39 PM
DAVIS STEPHENCEOOct 10Sale40.19120,2084,831,0390Oct 11 05:39 PM
DAVIS STEPHENCEOOct 09Option Exercise19.6529,792585,41329,792Oct 11 05:39 PM
DAVIS STEPHENCEOOct 09Sale40.0029,7921,191,7100Oct 11 05:39 PM
BAKER BROS. ADVISORS LPDirectorSep 20Buy40.001,562,50062,500,00037,470,965Sep 20 04:28 PM
Miller Eric AlejandroController & PAOSep 11Sale41.184,645191,2810Sep 11 07:19 PM
Daly James MDirectorSep 09Option Exercise17.5230,000525,60030,000Sep 11 07:18 PM
Miller Eric AlejandroController & PAOSep 09Option Exercise28.7128,467817,21833,112Sep 11 07:19 PM
Miller Eric AlejandroController & PAOSep 09Sale39.4928,4671,124,1624,645Sep 11 07:19 PM
Daly James MDirectorSep 09Sale37.8030,0001,133,8600Sep 11 07:18 PM